A new cancer therapy wakes up immune cells inside tumors and turns them against cancer.

In a groundbreaking study, scientists at the U.S. Department of Agriculture, Agricultural Research Service (ARS) redefined ...

KAIST researchers have developed a way to reprogram immune cells already inside tumors into cancer-killing machines. A drug ...

When Lisa Dutton was declared free of breast cancer in 2017, she took a moment to celebrate with family and friends, even though she knew her cancer journey might not be over. As many as one-third of ...

Immune checkpoint inhibitors (ICIs) have revolutionized cancer therapy by harnessing the body's immune system to target tumors. Despite their initial clinical success, many patients eventually ...

In Alchemy Factory, you’re here to brew explosive potions, transmute lead into gold, and maybe accidentally set your workshop on fire in the name of science. To conduct these explosive experiments, ...

Marissa Sulek joined CBS News Chicago in January 2025. Before Chicago, Marissa was a general assignment reporter in Nashville at WSMV, where she was nominated for Mid-South Emmy Awards for her ...

The treatment reprograms T cells to hunt down a patient's cancer. The approach could speed treatment and cut costs, but needs more study. With just a single injection, a new treatment transforms ...

Vice President JD Vance led Republicans’ attacks against Sen. Bernie Sanders (I-VT) after he killed a pediatric cancer bill. A landmark pediatric cancer bill was killed by Sanders before it could head ...

Newspaper buildings were set on fire after the death of an activist who was attacked recently. Political leaders fear more violence could derail attempts to restore democracy. By Saif Hasnat and Alex ...

Shares of Processa Pharmaceuticals PCSA surged 122.3% on Wednesday after the company provided an encouraging clinical update on its ongoing mid-stage study evaluating its investigational candidate NGC ...

NGC-Cap enhances exposure to cancer-killing metabolites without increasing side effect severity compared to capecitabine alone. Patients on NGC-Cap reported only mild hand-foot-syndrome symptoms, ...